Titan Biotech Limited (BOM:524717)

India · Delayed Price · Currency is INR

383.20

-8.30 (-2.12%)

At close: Oct 5, 2026

Market Cap	15.83B +97.8%
Revenue (ttm)	2.19B +36.9%
Net Income	338.79M +54.0%
EPS	8.20 +54.0%
Shares Out	41.32M
PE Ratio	46.74
Forward PE	n/a
Dividend	0.50 (0.13%)
Ex-Dividend Date	Sep 22, 2026

Volume	12,257
Open	392.45
Previous Close	391.50
Day's Range	380.25 - 397.95
52-Week Range	171.40 - 555.65
Beta	-0.51
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Titan Biotech

Titan Biotech Limited engages in the manufacture and sale of biological products in India and internationally. It offers food ingredients, including hydrolyzed vegetable protein, yeast extract powder, calcium propionate powder, potassium sorbate, and calcium lactate; collagen and protein products, such as wheat hydrolysate protein, corn hydrolysate protein, bovine collagen peptide, collagen peptide, fish collagen, undernatured chicken collagen type II, mucopolysaccharides, chicken protein isolate, soya protein isolate, and pea protein isolate; ... [Read more]

Industry Biological Products, Except Diagnostic Substances

Founded 1992

Employees 527

Stock Exchange Bombay Stock Exchange

Ticker Symbol 524717

Full Company Profile

Financial Performance

In fiscal year 2026, Titan Biotech's revenue was 2.06 billion, an increase of 31.79% compared to the previous year's 1.56 billion. Earnings were 298.85 million, an increase of 38.80%.

Financial Statements